+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025

  • PDF Icon

    Report

  • 270 Pages
  • August 2022
  • Region: Global
  • iGATE Research
  • ID: 4871463

The global point of care testing (POCT) market is predicted to reach nearly US$ 65 Billion by 2028. Point-of-care (POC) testing has skyrocketed in the last 20 years as demand for accurate and fast testing has blossomed both inside and outside the hospital setting. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. 

Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Furthermore, rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services. As per statistics of the International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes globally, and it is estimated to reach 643 million by 2030 and 783 million by 2045. Hence, growing infectious diseases and chronic conditions will enhance the point of care testing market in the near future.

Impact of COVID-19 on Global Point of Care Testing Market 

The COVID-19 outbreak has become a global stress test. The disease has infected around 596.2 million people worldwide. Globally the death toll has reached 6,456,879 according to the latest statistics from the Worldometers (as of August 16, 2022).  The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak stirred an unprecedented public health concern across the globe and has positively impacted the point of care testing market growth.  

The need for speedy diagnostic results has made point-of-care testing a vital diagnostic tool. The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. The usage of POC kits in COVID-19 diagnosis has increased at a significant pace owing to multiple advantages such as smaller size, portability, convenience, and precise outcomes, among others. These tests are capable of operating in any low-resource setting including home care settings and are needed to adequately combat the COVID-19 pandemic.

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment. Increasing prevalence of diabetes in developing as well as developed economies and the rising inclination of patients towards home testing is the major driver that will drive segmental growth over the forecast timeframe. 

The infectious diseases segment held second largest revenue share in 2021. Infectious diseases are the primary cause of mortality globally, and according to figures from the Clinical Microbiology and Infection journal, they claim over 14 million lives annually, making up around 25% of the 56 million deaths recorded worldwide. Infectious disease testing has shifted from centralized to decentralized POC testing, resulting in better patient care. The market is being driven by increased demand for quick tests, which has prompted industry players to deliver POC solutions to decentralized regions. For instance, Abbott has introduced ID NOW, the world's quickest molecular POC test, which provides COVID-19 findings in 13 minutes and is usable in a variety of decentralized healthcare settings.

Cardiac marker segment is expected to grow at a significant rate during the forecast period. The growing prevalence of cardiovascular ailments, increasing purchasing power, rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas is expected to drive the market for cardiac markers. 

By Mode - Global Point of Care Testing Market & Forecast

On the basis of mode, the point of care testing market is dominated by OTC-based testing segment. The segment is dominating the overall POCT market in 2021 as these tests are cost-effective as well as easy operative in nature. High segmental growth is attributed to rising number of OTC testing such as blood glucose tests and pregnancy tests that provides result in few seconds. These tests do not require skilled professional to perform and can be self-tested by individuals, thereby boosting the market growth. The Prescription based testing segment is expected to grow at the highest rate during the forecast period. 

By Platform - Global Point of Care Testing Market & Forecast

By platform, the Lateral Flow Assays (LFA) segment accounted for largest revenue share in 2021. POC tests based on lateral flow assays are increasingly being employed to replace long, conventional laboratory processes. Lateral flow assays are simple devices used to detect the presence or absence of target analytes in samples. These assays help in detecting and quantifying analytes in complex mixtures and provide results within 30 minutes after the sample is placed on the device. The point of care testing market for immunoassays technology is expected to witness significant growth over the forecast timeframe. Rapid immunoassays improve quality of care through its performance at point of care facilities, such as student health clinics, labor and delivery suites and emergency rooms. The cost-effectiveness offered by these immunoassays will influence segment growth during the forecast period. 

By End Users - Global Point of Care Testing Market & Forecast

Based on end users, the point of care testing market is segmented into Hospitals, Clinics, Laboratories, Home Care and Assisted Living Healthcare Facilities. Hospitals held majority of the point of care testing market, followed by Clinics. Increase in prevalence of chronic conditions such as cancer and cardiovascular diseases that require proper monitoring and prefer minimally invasive procedures are carried out in hospitals and clinics. The home care segment is expected to grow at the highest rate during the forecast period driven by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.  

By Region - Global Point of Care Testing Market & Forecast 

The point of care testing market, by region, is dominated by North America and is expected to maintain its position throughout the forecast period. This can be attributed to rising prevalence of chronic disorders and infectious diseases, which need portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives to support the adoption of POCT in this region. Europe held second highest share of the point of care testing market. Asia-Pacific point of care testing market is expected to grow at the fastest rate during the forecast period driven by growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies.

The report titled “Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028” provides a comprehensive analysis of the Global Point of Care Testing Market.

This 270 Page report with 78 Figures and 12 Tables has been analyzed from 11 View Points:

1) Global - Point of Care Testing Market & Forecast (2010 - 2028)
2) Impact of COVID-19 on Global Point of Care Testing Market
3) Global - Point of Care Testing Market Share and Forecast (2010 - 2028)
4) By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)
5) By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)
6) By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)
7) By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)
8) By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)
9) Global Point of Care Testing Market - Recent Developments 
10) Global Point of Care Testing Market - 106 Company Profiles 
11) Global Point of Care Testing Market - Growth Drivers & Challenges

Table of Contents


1. Executive Summary2. Impact of COVID-19 on Global Point of Care Testing Market3. Global - Point of Care Testing Market & Forecast (2010 - 2028)
4. Global - Point of Care Testing Market Share & Forecast (2010 - 2028)
4.1 By Diagnostics Segment - Global Point of Care Testing Market Share & Forecast
4.2 By Mode - Global Point of Care Testing Market Share & Forecast
4.3 By Platform - Global Point of Care Testing Market Share & Forecast (2015 - 2028)
4.4 By End Users - Global Point of Care Testing Market Share & Forecast
4.5 By Region - Point of Care Testing Market Share & Forecast

5. By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)
5.1 Blood Glucose Testing Market & Forecast
5.2 Cardiac Marker Testing Market & Forecast
5.3 Lipid Panel/Cholesterol Testing Market & Forecast
5.4 Coagulation Testing Market & Forecast
5.5 Infectious Disease Testing Market & Forecast
5.6 Urinalysis Testing Market & Forecast
5.7 Drug of Abuse Testing Market & Forecast
5.8 Fecal Occult Blood Testing Market & Forecast
5.9 Pregnancy & Fertility Testing Market & Forecast
5.10 Tumor Marker Testing Market & Forecast
5.11 Critical Care Testing Market & Forecast
5.12 HbA1c Testing Market & Forecast
5.13 Clinical Chemistry Testing Market & Forecast
5.14 Bilirubin Testing Market & Forecast
5.15 Hematology Testing Market & Forecast

6. By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)
6.1 Prescription-based Testing Market & Forecast
6.2 OTC-based Testing Market & Forecast

7. By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)
7.1 Global - Point of Care Diagnostics Market for Lateral Flow Assays
7.2 Global - Point of Care Diagnostics Market for Immunoassays
7.3 Global - Point of Care Diagnostics Market for Microfluidics
7.4 Global - Point of Care Diagnostics Market for Dipsticks
7.5 Global - Point of Care Diagnostics Market for Molecular Diagnostics
7.6 Global - Point of Care Diagnostics Market for Other Platforms

8. By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)
8.1 Hospitals - Point of Care Testing Market & Forecast
8.2 Clinics - Point of Care Testing Market & Forecast
8.3 Laboratories - Point of Care Testing Market & Forecast
8.4 Assisted Living Healthcare Facilities - Point of Care Testing Market & Forecast
8.5 Home Care - Point of Care Testing Market & Forecast

9. By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)
9.1 North America - Point of Care Testing Market & Forecast
9.2 Europe - Point of Care Testing Market & Forecast
9.3 Asia Pacific - Point of Care Testing Market & Forecast
9.4 Latin America - Point of Care Testing Market & Forecast
9.5 Middle East and Africa - Point of Care Testing Market & Forecast

10. Global Point of Care Testing Market - Recent Developments
11. Point of Care Testing Market - Company Profiles
11.1 Abbott Laboratories
11.1.1 Company Overview
11.1.2 Product Portfolio
11.1.3 Financial Insight
11.1.4 Business Strategy
11.2 Siemens Healthineers
11.2.1 Company Overview
11.2.2 Product Portfolio
11.2.3 Financial Insight
11.2.4 Business Strategy
11.3 Roche Diagnostics
11.3.1 Company Overview
11.3.2 Product Portfolio
11.3.3 Financial Insight
11.3.4 Business Strategy
11.4 Quest Diagnostics
11.4.1 Company Overview
11.4.2 Product Portfolio
11.4.3 Financial Insight
11.4.4 Business Strategy
11.5 Becton, Dickinson and Company
11.5.1 Company Overview
11.5.2 Product Portfolio
11.5.3 Financial Insight
11.5.4 Business Strategy
11.6 ACON Laboratories
11.6.1 Company Overview
11.6.2 Product Portfolio
11.7 Abaxis, Inc.
11.7.1 Company Overview
11.7.2 Product Portfolio
11.8 Abingdon Health, Ltd.
11.8.1 Company Overview
11.8.2 Product Portfolio
11.9 Access Bio, Inc.
11.9.1 Company Overview
11.9.2 Product Portfolio
11.10 AccuBioTech Co, Ltd.
11.11 Akers Biosciences, Inc.
11.12 Alfa Scientific Designs, Inc
11.13 American Bio Medica Corporation
11.14 AmniSure International
11.15 Aquila Diagnostic Systems, Inc
11.16 ARKRAY Inc
11.17 Artron Laboratories Inc.
11.18 Ascensia Diabetes Care Holdings AG
11.19 Immune IQ (Formerly Ativa)
11.20 Atlas Link Biotech Co., Ltd
11.21 Audit Diagnostics
11.22 Augurix Diagnostics
11.23 Autobio Diagnostics Co., Ltd
11.24 Axxin
11.25 Beckman Coulter, Inc
11.26 Bhat Bio-Tech India Private Ltd. (BBI)
11.27 bioLytical Laboratories
11.28 BioMedomics, Inc
11.29 Biomerica, Inc.
11.30 bioMerieux SA
11.31 Biophor Diagnostics, Inc
11.32 Biosensia Ltd.
11.33 Bio-Rad Laboratories Inc.
11.34 Bioscan Screening Systems, Inc.
11.35 BTNX Inc.
11.36 Boditech Med Inc
11.37 Xiamen Boson Biotech Co. Ltd
11.38 Calypte Biomedical Corporation
11.39 Cepheid, Inc
11.40 Chembio Diagnostic Systems, Inc.
11.41 Clarity Diagnostics, LLC
11.42 Confirm Biosciences
11.43 CTK Biotech, Inc.
11.44 Daktari Diagnostics
11.45 Danaher Corporation
11.46 Dexcom, Inc
11.47 DIALAB GmbH
11.48 DiaSys Diagnostic Systems GmbH
11.49 Diazyme Laboratories, Inc.
11.50 DNA Electronics Ltd. (DNAe)
11.51 EKF Diagnostics Holdings plc
11.52 ELITechGroup, Inc.
11.53 Eurolyser Diagnostica GmbH
11.54 Exact Sciences Corporation
11.55 Exalenz Bioscience Ltd.
11.56 Genedrive plc
11.57 GeTein BioMedical, Inc.
11.58 Helena Laboratories
11.59 Hemosure, Inc.
11.60 Immunostics, Inc.
11.61 Instrumentation Laboratory
11.62 JAL Innovation PTE LTD
11.63 Jant Pharmacal Corporation
11.64 LamdaGen Corporation
11.65 LifeScan, Inc
11.66 LifeSign, LLC
11.67 MBio Diagnostics, Inc (Now LightDeck Diagnostics)
11.68 Medix Biochemica
11.69 Medtronic, Inc.
11.70 A. Menarini Diagnostics S.R.L.
11.71 Meridian Bioscience, Inc
11.72 Nano-Ditech Corporation
11.73 Noble Medical, Inc
11.74 Nova Biomedical, Corp.
11.75 Oasis Diagnostics Corporation
11.76 OPKO Health, Inc
11.77 OPTI Medical Systems, Inc
11.78 OraSure Technologies, Inc
11.79 Polymed Therapeutics Inc.
11.80 Preventis GmbH
11.81 Princeton Biomeditech Corporation
11.82 QuantuMDx Group Limited
11.83 Radiometer Medical A/S
11.84 Response Biomedical Corp
11.85 Reszon Diagnostics International Sdn. Bhd.
11.86 Samsung Healthcare
11.87 Savyon Diagnostics
11.88 Sekisui Diagnostics LLC
11.89 Siloam Biosciences, Inc
11.90 Sysmex Corporation
11.91 TECHLAB, Inc.
11.92 Teco Diagnostics
11.93 Trinity Biotech PLC
11.94 Trividia Health
11.95 Tulip Diagnostics Ltd
11.96 Veredus Laboratories PTE Ltd
11.97 Vircell
11.98 WAMA Diagnostica
11.99 Wave 80 Biosciences
11.100 Werfen
11.101 Quidel Corporation
11.102 Thermo Fisher Scientific
11.103 Mesa Biotech Inc.
11.104 GeneSTAT Molecular Diagnostics, LLC
11.105 Biocartis Group NV
11.106 Johnson and Johnson Service, Inc.

12. Global Point of Care Testing Market - Growth Drivers
12.1 Point-of-care Testing: A Step to the Future
12.2 High Prevalence of Chronic and Infectious Diseases
12.3 Continued Expansion of Point of Care Including Self Testing
12.3.1 The Promise of Point-of-Care Testing
12.3.2 Future of Point of Care Testing - The ‘Worried Well’
12.3.3 Hub and Spoke
12.3.4 Education
12.4 Technological Advancement in POCT to Spur Market Demand

13. Global Point of Care Testing Market - Challenges
13.1 Point of Care (POC) Testing Barriers in Low & Middle-Income Countries
13.1.1 Barriers to Adoption & Scale-up of POC Technologies
13.1.2 Technical, Administrative & Operational Barriers of Point of Care Tests
13.1.3 Health System Related Barriers of Point of Care Tests
13.1.4 Economic Barriers of Point of Care Tests
13.2 Policy/Regulatory Guidelines and Funding Challenges
13.3 Infrastructure Barriers and Challenges with POC Diagnostics Development

List of Figures:
Figure 3-1: Global - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 3-2: Global - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 5-1: Global - Blood Glucose Testing Market (Million US$), 2010 - 2021
Figure 5-2: Global - Forecast for Blood Glucose Testing Market (Million US$), 2022 - 2028
Figure 5-3: Global - Cardiac Marker Testing Market (Million US$), 2010 - 2021
Figure 5-4: Global - Forecast for Cardiac Marker Testing Market (Million US$), 2022 - 2028
Figure 5-5: Global - Lipid Panel/Cholesterol Testing Market (Million US$), 2010 - 2021
Figure 5-6: Global - Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2022 - 2028
Figure 5-7: Global - Coagulation Testing Market (Million US$), 2010 - 2021
Figure 5-8: Global - Forecast for Coagulation Testing Market (Million US$), 2022 - 2028
Figure 5-9: Global - Infectious Disease Testing Market (Million US$), 2010 - 2021
Figure 5-10: Global - Forecast for Infectious Disease Testing Market (Million US$), 2022 - 2028
Figure 5-11: Global - Urinalysis Testing Market (Million US$), 2010 - 2021
Figure 5-12: Global - Forecast for Urinalysis Testing Market (Million US$), 2022 - 2028
Figure 5-13: Global - Drug of Abuse Testing Market (Million US$), 2010 - 2021
Figure 5-14: Global - Forecast for Drug of Abuse Testing Market (Million US$), 2022 - 2028
Figure 5-15: Global - Fecal Occult Blood Testing Market (Million US$), 2010 - 2021
Figure 5-16: Global - Forecast for Fecal Occult Blood Testing Market (Million US$), 2022 - 2028
Figure 5-17: Global - Pregnancy & Fertility Testing Market (Million US$), 2010 - 2021
Figure 5-18: Global - Forecast for Pregnancy & Fertility Testing Market (Million US$), 2022 - 2028
Figure 5-19: Global - Tumor Marker Testing Market (Million US$), 2010 - 2021
Figure 5-20: Global - Forecast for Tumor Marker Testing Market (Million US$), 2022 - 2028
Figure 5-21: Global - Critical Care Testing Market (Million US$), 2010 - 2021
Figure 5-22: Global - Forecast for Critical Care Testing Market (Million US$), 2022 - 2028
Figure 5-23: Global - HbA1c Testing Market (Million US$), 2010 - 2021
Figure 5-24: Global - Forecast for HbA1c Testing Market (Million US$), 2022 - 2028
Figure 5-25: Global - Clinical Chemistry Testing Market (Million US$), 2010 - 2021
Figure 5-26: Global - Forecast for Clinical Chemistry Testing Market (Million US$), 2022 - 2028
Figure 5-27: Global - Bilirubin Testing Market (Million US$), 2010 - 2021
Figure 5-28: Global - Forecast for Bilirubin Testing Market (Million US$), 2022 - 2028
Figure 5-29: Global - Hematology Testing Market (Million US$), 2010 - 2021
Figure 5-30: Global - Forecast for Hematology Testing Market (Million US$), 2022 - 2028
Figure 6-1: Global - Prescription-based Testing Market (Million US$), 2010 - 2021
Figure 6-2: Global - Forecast for Prescription-based Testing Market (Million US$), 2022 - 2028
Figure 6-3: Global - OTC-based Testing Market (Million US$), 2010 - 2021
Figure 6-4: Global - Forecast for OTC-based Testing Market (Million US$), 2022 - 2028
Figure 7-1: Global POCT - Lateral Flow Assays Market (Million US$), 2015 - 2021
Figure 7-2: Global POCT - Forecast for Lateral Flow Assays Market (Million US$), 2022 - 2028
Figure 7-3: Global POCT - Immunoassays Market (Million US$), 2015 - 2021
Figure 7-4: Global POCT - Forecast for Immunoassays Market (Million US$), 2022 - 2028
Figure 7-5: Global POCT - Microfluidics Market (Million US$), 2015 - 2021
Figure 7-6: Global POCT - Forecast for Microfluidics Market (Million US$), 2022 - 2028
Figure 7-7: Global POCT - Dipsticks Market (Million US$), 2015 - 2021
Figure 7-8: Global POCT - Forecast for Dipsticks Market (Million US$), 2022 - 2028
Figure 7-9: Global POCT - Molecular Diagnostics Market (Million US$), 2015 - 2021
Figure 7-10: Global POCT - Forecast for Molecular Diagnostics Market (Million US$), 2022 - 2028
Figure 7-11: Global POCT - Other Platforms Market (Million US$), 2015 - 2021
Figure 7-12: Global POCT - Forecast for Other Platforms Market (Million US$), 2022 - 2028
Figure 8-1: Hospitals - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 8-2: Hospitals - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 8-3: Clinics - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 8-4: Clinics - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 8-5: Laboratories - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 8-6: Laboratories - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 8-7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 8-8: Assisted Living Healthcare Facilities - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 8-9: Home Care - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 8-10: Home Care - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 9-1: North America - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 9-2: North America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 9-3: Europe - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 9-4: Europe - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 9-5: Asia Pacific - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 9-6: Asia Pacific - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 9-7: Latin America - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 9-8: Latin America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 9-9: Middle East and Africa - Point of Care Testing Market (Million US$), 2010 - 2021
Figure 9-10: Middle East and Africa - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
Figure 11-1: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2021
Figure 11-2: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
Figure 11-3: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2021
Figure 11-4: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
Figure 11-5: Roche Diagnostics - Global Sales (Million US$), 2013 - 2021
Figure 11-6: Roche Diagnostics - Forecast for Global Sales (Million US$), 2022 - 2028
Figure 11-7: Quest Diagnostics - Net Sales (Million US$), 2014 - 2021
Figure 11-8: Quest Diagnostics - Forecast for Net Sales (Million US$), 2022 - 2028
Figure 11-9: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2021
Figure 11-10: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028

List of Tables:
Table 4-1: By Diagnostics Segment - Global Point of Care Testing Market Share (Percent), 2010 - 2021
Table 4-2: By Diagnostics Segment - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
Table 4-3: By Mode - Global Point of Care Testing Market Share (Percent), 2010 - 2021
Table 4-4: By Mode - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
Table 4-5: By Platform - Global Point of Care Testing Market Share (Percent), 2015 - 2021
Table 4-6: By Platform - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
Table 4-7: By End Users - Global Point of Care Testing Market Share (Percent), 2010 - 2021
Table 4-8: By End Users - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
Table 4-9: By Region - Point of Care Testing Market Share (Percent), 2010 - 2021
Table 4-10: By Region - Forecast for Point of Care Testing Market Share (Percent), 2022 - 2028
Table 11-1: Eurolyser Diagnostica GmbH - Point-of-Care Test Portfolio
Table 13-1: POCT - Barriers to Adoption and Scale-up of POC Technologies

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Siemens Healthineers
  • Roche Diagnostics
  • Quest Diagnostics
  • Becton, Dickinson and Company
  • ACON Laboratories
  • Abaxis, Inc
  • Abingdon Health, Ltd
  • Access Bio, Inc.
  • AccuBioTech Co, Ltd.
  • Akers Biosciences, Inc.
  • Alfa Scientific Designs, Inc
  • American Bio Medica Corporation
  • AmniSure International
  • Aquila Diagnostic Systems, Inc
  • ARKRAY Inc
  • Artron Laboratories Inc.
  • Ascensia Diabetes Care Holdings AG
  • Immune IQ (Formerly Ativa)
  • Atlas Link Biotech Co., Ltd
  • Audit Diagnostics
  • Augurix Diagnostics
  • Autobio Diagnostics Co., Ltd
  • Axxin
  • Beckman Coulter, Inc
  • Bhat Bio-Tech India Private Ltd.
  • bioLytical Laboratories
  • BioMedomics, Inc
  • Biomerica, Inc.
  • bioMerieux SA
  • Biophor Diagnostics, Inc
  • Bio-Rad Laboratories Inc.
  • Bioscan Screening Systems, Inc.
  • Biosensia Ltd.
  • BTNX Inc.
  • Boditech Med Inc
  • Xiamen Boson Biotech Co. Ltd
  • Calypte Biomedical Corporation
  • Cepheid, Inc
  • Chembio Diagnostic Systems, Inc
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Daktari Diagnostics
  • Danaher Corporation
  • Dexcom, Inc
  • DIALAB GmbH
  • DiaSys Diagnostic Systems GmbH
  • Diazyme Laboratories, Inc.
  • DNA Electronics Ltd. (DNAe)
  • EKF Diagnostics Holdings plc
  • ELITechGroup, Inc.
  • Eurolyser Diagnostica GmbH
  • Exact Sciences Corporation
  • Exalenz Bioscience Ltd
  • Genedrive plc
  • GeTein BioMedical, Inc.
  • Helena Laboratories
  • Hemosure, Inc.
  • Immunostics, Inc.
  • Instrumentation Laboratory
  • JAL Innovation PTE LTD
  • Jant Pharmacal Corporation
  • LamdaGen Corporation
  • LifeScan, Inc
  • LifeSign, LLC
  • MBio Diagnostics, Inc (Now LightDeck Diagnostics)
  • Medix Biochemica
  • Medtronic, Inc
  • A. Menarini Diagnostics S.R.L.
  • Meridian Bioscience, Inc
  • Nano-Ditech Corporation
  • Noble Medical, Inc
  • Nova Biomedical, Corp.
  • Oasis Diagnostics Corporation
  • OPKO Health, Inc
  • OPTI Medical Systems, Inc
  • OraSure Technologies, Inc
  • Polymed Therapeutics Inc.
  • Preventis GmbH
  • Princeton Biomeditech Corporation
  • QuantuMDx Group Limited
  • Radiometer Medical A/S
  • Response Biomedical Corp
  • Reszon Diagnostics International Sdn. Bhd.
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics LLC
  • Siloam Biosciences, Inc
  • Sysmex Corporation
  • TECHLAB, Inc.
  • Teco Diagnostics
  • Trinity Biotech PLC
  • Trividia Health
  • Tulip Diagnostics Ltd
  • Veredus Laboratories PTE Ltd
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen
  • Quidel Corporation
  • Thermo Fisher Scientific
  • Mesa Biotech Inc
  • GeneSTAT Molecular Diagnostics, LLC
  • Biocartis Group NV
  • Johnson and Johnson Service, Inc.
  •